Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4644124
Max Phase: Preclinical
Molecular Formula: C54H79N13O14S2
Molecular Weight: 1198.44
Molecule Type: Unknown
Associated Items:
ID: ALA4644124
Max Phase: Preclinical
Molecular Formula: C54H79N13O14S2
Molecular Weight: 1198.44
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCN(CC)C(=S)SCc1ccc(NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](N)CO)cc1
Standard InChI: InChI=1S/C54H79N13O14S2/c1-5-67(6-2)54(82)83-29-33-9-15-34(16-10-33)59-47(76)39(22-30(3)4)61-50(79)42(26-69)65-49(78)41(24-32-13-19-36(73)20-14-32)62-48(77)40(23-31-11-17-35(72)18-12-31)63-51(80)43(27-70)66-52(81)44(28-71)64-46(75)38(8-7-21-58-53(56)57)60-45(74)37(55)25-68/h9-20,30,37-44,68-73H,5-8,21-29,55H2,1-4H3,(H,59,76)(H,60,74)(H,61,79)(H,62,77)(H,63,80)(H,64,75)(H,65,78)(H,66,81)(H4,56,57,58)/t37-,38+,39+,40+,41+,42+,43+,44+/m1/s1
Standard InChI Key: FJPQQBAHLYRLOH-JMNYKWSOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1198.44 | Molecular Weight (Monoisotopic): 1197.5311 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Bakthavatsalam S, Wiangnak P, George DJ, Zhang T, Franz KJ.. (2020) Dithiocarbamate prodrugs activated by prostate specific antigen to target prostate cancer., 30 (11): [PMID:32253061] [10.1016/j.bmcl.2020.127148] |
Source(1):